Developer docs
API playgroundTry for free, no card

Search company profiles

Seegnal eHealth

Full company profile

uuid0005u1c

Namestring
Seegnal eHealth
Legal namestring
Seegnal eHealth Ltd.
Websiteurl
seegnal.com
Company typeenum
Public
Founded yearint
2020
Descriptiontext

Seegnal eHealth Ltd. is an Israel-headquartered healthcare technology company (with operational offices in Calgary, Canada and Rockville, Maryland) that has built a Prescription Operating System — an EMR-integrated clinical decision support platform that delivers real-time, patient-specific medication decision support at the point of care. The platform comprises three integrated modules: Seegnal DRP (Decision Risk Prevention) for point-of-care safety and real-time error prevention, Seegnal Insights (Behavior and Outcome Learning) for system-wide prescribing analytics, and Seegnal Guard (Governance and Optimization) for executive policy management. A newer MetricsGuard module (launched Q4 2025) extends detection of patient-specific medication risks. The system pulls medications, labs, vitals, diagnoses, allergies, and pharmacogenomic data from the EMR in real time and evaluates 500+ clinical rules using a hybrid rules-engine and machine-learning architecture, producing context-aware alerts, ranked therapeutic alternatives, and pre-prescription simulation. Seegnal holds four granted patents (U.S. 10872079, 10387406, 10592501; Canadian 2829100) protecting its patented slider UI, ranked-alternatives engine, simulation mode, and contextual adaptive intelligence.

The company serves enterprise healthcare buyers — acute-care hospitals, health maintenance organizations, and increasingly long-term and senior care facilities — with anchor deployments including Tel Aviv Sourasky Medical Center (~1,200 clinicians, 2,050 medical team members), Maccabi Healthcare Services (6,252 physicians onboarded in six months, 60,000+ prescriptions screened daily), and Leumit Health Services. The platform is in active use by 15,000-20,000 clinicians, protects 3.5M+ patients per day, and processes 400,000+ prescriptions daily across three countries. Israel's Ministry of Health has endorsed the platform as a patient-specific standard for governmental hospitals, and peer-reviewed outcomes include a 94% reduction in alert volume versus legacy CDS, 35% fewer adverse drug events, a 5.6% reduction in drug-related hospitalizations, and a 12% reduction in readmissions.

Seegnal monetizes via annual enterprise SaaS subscriptions priced per healthcare organization (quote-based, not publicly disclosed), distributes exclusively through direct enterprise sales with CEO-led commercial accountability, and completed its TSX Venture Exchange listing (ticker SEGN) in late 2025/early 2026. Under CEO Elad Bibi-Aviv (appointed December 2025) and a newly formed Strategic Commercialization Team, the company is shifting from clinical proof-of-concept to structured commercialization, with U.S. market entry initiated via a long-term care pilot LOI in May 2026 and AARP AgeTech Collaborative accelerator acceptance in June 2026. Headcount stands at 11-50 employees, and an ongoing non-brokered private placement is funding the commercial scale-up.

Short descriptiontext

Seegnal eHealth provides a Prescription Operating System — an EMR-integrated, AI-driven clinical decision support platform delivering real-time medication safety, prescribing analytics, and governance for hospitals, HMOs, and senior care facilities across Israel, Canada, and the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRockville, United States
HQ citystring
Rockville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, medication safety software, prescription analytics platform, EMR-integrated prescribing, healthcare SaaS solutions
Industry3 codes
1Virtual Pharmacy & Medication Management Integration Platforms
CodeHLALABALPrimaryYes
2Clinical Decision Support & Workflow Integration (EHR/oncology systems)
CodeHLAAANAEPrimaryNo
3Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
CodeHLALAIAHPrimaryNo
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Health Services8000
  • Services-Computer Integrated Systems Design7373
Product category
Clinical Decision Support Software
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Clinical Decision Support Subscription
TypeSubscription Recurring
Description

Seegnal operates as a TSXV-listed SaaS company providing clinical decision support solutions on a subscription basis. The platform delivers measurable clinical ROI through its Prescription Operating System with pricing likely based on organization size or prescription volume.

newswire.ca
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Others
Pricing details1 tier
1Enterprise SaaS pricing for healthcare systems
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

seegnal.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Seegnal DRP
Description

Decision Risk Prevention - Point-of-care safety and rules engine preventing medication errors in real-time.

seegnal.com
+3 more records
Core offering1 text field

Seegnal eHealth sells the Seegnal Prescription Operating System, an enterprise clinical decision support platform that delivers real-time, patient-specific medication safety at the point of care. The platform integrates directly into EMR/EHR workflows and processes medications, labs, vitals, organ function, diagnoses, allergies, and genomic data through a hybrid rules-based engine and machine learning models, evaluating 500+ clinical rules in milliseconds. The platform is sold to healthcare systems, hospitals, and HMOs on a SaaS subscription basis and is structured as three integrated modules (Seegnal DRP, Seegnal Insights, Seegnal Guard) plus the MetricsGuard module.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 94% fewer alerts compared to legacy clinical decision support systems
+9 more records
Product overview1 text field

Seegnal eHealth is an enterprise healthcare technology company offering the Seegnal Prescription Operating System—a unified platform for precision prescribing and measurable clinical ROI. The platform comprises three integrated modules: Seegnal DRP (Decision Risk Prevention) for point-of-care medication safety and real-time error prevention; Seegnal Insights (Behavior and Outcome Learning) for system-wide prescribing analytics, pattern detection, and cost optimization; and Seegnal Guard (Governance and Optimization) for executive-level policy management and continuous improvement. Together, these three modules form a closed intelligence flywheel where every prescribing event feeds the system, successful interventions inform better future alerts, and Insights findings refine DRP rules. The platform delivers real-time, patient-specific decision support embedded directly in EMR workflows, processing medications, labs, vitals, diagnoses, allergies, and genomic data to reduce medication-related risk while enabling health systems to lower avoidable downstream costs.

Product and service5 records
1Seegnal Prescription Operating System
CategoryClinical Decision Support Platform
Description

Enterprise healthcare technology platform delivering precision prescribing and measurable clinical ROI. The core Prescription OS unifies three integrated layers (Seegnal DRP, Seegnal Insights, Seegnal Guard) into a continuous intelligence flywheel that improves safety, drives adoption, and compounds clinical and financial value over time for healthcare systems, hospitals, and HMOs.

2Seegnal DRP (Decision Risk Prevention)
CategoryClinical Decision Support Module
Description

Real-time prescription safety engine integrated directly into the clinician's workflow, preventing medication errors before they happen through continuous safety logic, drug interaction alerts, renal adjustment recommendations, alternative therapy suggestions, and AI-ranked alternatives from formulary tailored to patient history, allergies, and genetics. Built for clinicians in hospitals, HMOs, and long-term care facilities.

3Seegnal Insights (Behavior + Outcome Learning)
CategoryHealthcare Analytics Module
Description

Behavior and outcome learning module providing system-wide analytics that expose prescribing patterns, safety gaps, and cost optimization opportunities. Identifies variation across facilities and providers, detects unsafe patterns and trends, surfaces waste and inefficiencies, and delivers role-specific dashboards for executive, operational, and clinical stakeholders. Built for healthcare system leadership, quality teams, and CFOs.

4Seegnal Guard (Governance + Optimization)
CategoryClinical Governance Module
Description

Governance and optimization module providing executive visibility and KPIs for continuous organization-level improvement. Functions as a clinical security center that defines, enforces, and monitors organizational prescribing policies — both clinical and economic — with policy builder, compliance tracking, and automated enforcement at point of care without requiring emails, policing, or training cycles. Built for healthcare executives, CMOs, and clinical leadership.

5MetricsGuard
CategoryClinical Decision Support Module
Description

Clinical decision support module designed to detect patient-specific medication risks, improving clinical safety and reducing adverse drug effects as part of the broader Prescription Intelligence Platform for healthcare systems and providers.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-05
Description

Seegnal was accepted into the innovative accelerator program from AARP, the largest U.S. organization serving Americans 50 and older. The program offers mentorship, consumer insights, and potential connections to investors and partners, with focus on U.S. market entry and expansion. This is a strategic accelerator partnership aimed at supporting companies serving Americans aged 50 and older. Participation does not constitute an endorsement by AARP.

2U.S.-Based Long-Term Care Provider
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Seegnal entered into a non-binding letter of intent dated May 5, 2026, with a U.S.-based long-term care provider to conduct an 8 to 12-week pilot program of its clinical decision support platform for analyzing prescription data and identifying medication-related risks. This pilot marks Seegnal's first engagement in the American healthcare market and represents a deliberate entry point for broader U.S. commercial expansion strategy. The long-term care setting was chosen because the resident population faces elevated risk of adverse drug events that drive avoidable hospitalizations.

globenewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Expanded deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a leading Israeli public medical center and global referral center. The platform supports approximately 1,200 clinicians and 2,050 medical team members across multiple inpatient and outpatient departments. The medical center treats over 1.5 million patients annually and has adopted Seegnal's patient-centric medication safety standard as a case model for large-scale deployment in public healthcare systems worldwide.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Engaged CapitaLynx Ltd. (operating as Arx) as an investor relations advisor commencing April 1, 2026, under a three-month initial term at US$49,500 with automatic quarterly renewal. This advisory engagement supports Seegnal's transition from clinical proof-of-concept to structured commercialization.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MedAware is an Israel-based developer of AI-powered medication safety software that flags prescription errors and risks inside EMR workflows. Directly comparable in technology stack (AI on patient data + EMR-native delivery) and in origin (Israel's digital health ecosystem).

TypeBroad incumbent
Description

Surescripts operates the dominant U.S. ePrescribing network and offers medication history, benefit, and clinical decision support services used by EHRs, pharmacies, and payers. Comparable on the ePrescribing/medication-decision support layer that Seegnal's Prescription OS integrates with.

TypeBroad incumbent
Description

Epic is the dominant U.S. hospital EMR vendor and offers native clinical decision support (Best Practice Advisories) and embedded medication alerts. Most relevant as the bundled incumbent whose CDS roadmap could expand to subsume Seegnal-type functionality for large U.S. health systems.

TypeDirect peer
Description

Arine is an AI-driven medication intelligence platform for health plans and providers that optimizes prescribing for value-based care. It targets the same precision-prescribing and adverse-drug-event reduction problem Seegnal addresses, with similar data-driven alerting and alternative-ranking capabilities.

TypeDirect peer
Description

DrFirst provides ePrescribing, medication management, and clinical decision support technology used by hospitals, EMRs, and pharmacy networks. Comparable on medication-management workflow integration and patient-specific decision support embedded in prescriber systems.

TypeBroad incumbent
Description

Oracle Health (formerly Cerner) is a leading hospital EMR vendor with embedded medication alerts and clinical decision support. Notable as both an integration partner of Seegnal (via Oracle Health EMR real-time sync) and a competitor whose first-party CDS could expand.

TypeDirect peer
Description

First Databank provides drug knowledge databases (FDB MedKnowledge) and clinical decision support modules integrated into EMR workflows for hospital and pharmacy systems. Directly comparable to Seegnal DRP for medication-safety screening at point of care.

8Tabula Rasa HealthCare (now CareVention)
TypeDirect peer
Description

Tabula Rasa HealthCare (now CareVention) provided medication safety analytics and pharmacy risk management focused on reducing adverse drug events for high-risk patients, including long-term care populations. Directly comparable to Seegnal's mission and medication-risk-prevention focus.

TypeDirect peer
Description

Wolters Kluwer's Medi-Span and Lexicomp provide drug-interaction, dosing, and clinical-decision-support content used by hospitals and health systems worldwide. Like Seegnal, it sits inside EMR workflows to prevent prescribing errors and optimize therapy choices.

TypeBroad incumbent
Description

Elsevier Clinical Solutions offers drug reference content (Gold Standard) and clinical decision support used by hospitals and EMR vendors. Overlaps with Seegnal DRP content and integration approach but ships as part of Elsevier's broader clinical-information portfolio rather than a standalone prescribing OS.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Seegnal eHealth

Clinical Decision Support Softwareseegnal.com

Seegnal eHealth provides a Prescription Operating System — an EMR-integrated, AI-driven clinical decision support platform delivering real-time medication safety, prescribing analytics, and governance for hospitals, HMOs, and senior care facilities across Israel, Canada, and the United States.

What Seegnal eHealth does

Seegnal eHealth Ltd. is an Israel-headquartered healthcare technology company (with operational offices in Calgary, Canada and Rockville, Maryland) that has built a Prescription Operating System — an EMR-integrated clinical decision support platform that delivers real-time, patient-specific medication decision support at the point of care. The platform comprises three integrated modules: Seegnal DRP (Decision Risk Prevention) for point-of-care safety and real-time error prevention, Seegnal Insights (Behavior and Outcome Learning) for system-wide prescribing analytics, and Seegnal Guard (Governance and Optimization) for executive policy management. A newer MetricsGuard module (launched Q4 2025) extends detection of patient-specific medication risks. The system pulls medications, labs, vitals, diagnoses, allergies, and pharmacogenomic data from the EMR in real time and evaluates 500+ clinical rules using a hybrid rules-engine and machine-learning architecture, producing context-aware alerts, ranked therapeutic alternatives, and pre-prescription simulation. Seegnal holds four granted patents (U.S. 10872079, 10387406, 10592501; Canadian 2829100) protecting its patented slider UI, ranked-alternatives engine, simulation mode, and contextual adaptive intelligence.

The company serves enterprise healthcare buyers — acute-care hospitals, health maintenance organizations, and increasingly long-term and senior care facilities — with anchor deployments including Tel Aviv Sourasky Medical Center (~1,200 clinicians, 2,050 medical team members), Maccabi Healthcare Services (6,252 physicians onboarded in six months, 60,000+ prescriptions screened daily), and Leumit Health Services. The platform is in active use by 15,000-20,000 clinicians, protects 3.5M+ patients per day, and processes 400,000+ prescriptions daily across three countries. Israel's Ministry of Health has endorsed the platform as a patient-specific standard for governmental hospitals, and peer-reviewed outcomes include a 94% reduction in alert volume versus legacy CDS, 35% fewer adverse drug events, a 5.6% reduction in drug-related hospitalizations, and a 12% reduction in readmissions.

Seegnal monetizes via annual enterprise SaaS subscriptions priced per healthcare organization (quote-based, not publicly disclosed), distributes exclusively through direct enterprise sales with CEO-led commercial accountability, and completed its TSX Venture Exchange listing (ticker SEGN) in late 2025/early 2026. Under CEO Elad Bibi-Aviv (appointed December 2025) and a newly formed Strategic Commercialization Team, the company is shifting from clinical proof-of-concept to structured commercialization, with U.S. market entry initiated via a long-term care pilot LOI in May 2026 and AARP AgeTech Collaborative accelerator acceptance in June 2026. Headcount stands at 11-50 employees, and an ongoing non-brokered private placement is funding the commercial scale-up.

Seegnal eHealth firmographics

Firmographics
Name
Seegnal eHealth
Legal name
Seegnal eHealth Ltd.
Website
https://seegnal.com
Company type
Public
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Seegnal eHealth provides a Prescription Operating System — an EMR-integrated, AI-driven clinical decision support platform delivering real-time medication safety, prescribing analytics, and governance for hospitals, HMOs, and senior care facilities across Israel, Canada, and the United States.
Ownership category
akta.pro rank

Seegnal eHealth industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
akta.pro secondary industries
Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

Keywords

  • Clinical decision support
  • Medication safety software
  • Prescription analytics platform
  • EMR-integrated prescribing
  • Healthcare SaaS solutions

Where Seegnal eHealth is headquartered

Location

Headquarters

HQ city
Rockville
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Seegnal eHealth business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

  1. SaaS Clinical Decision Support Subscription: Seegnal operates as a TSXV-listed SaaS company providing clinical decision support solutions on a subscription basis. The platform delivers measurable clinical ROI through its Prescription Operating System with pricing likely based on organization size or prescription volume.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS pricing for healthcare systems

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Seegnal eHealth product offering

Product offering

Core offering

Seegnal eHealth sells the Seegnal Prescription Operating System, an enterprise clinical decision support platform that delivers real-time, patient-specific medication safety at the point of care. The platform integrates directly into EMR/EHR workflows and processes medications, labs, vitals, organ function, diagnoses, allergies, and genomic data through a hybrid rules-based engine and machine learning models, evaluating 500+ clinical rules in milliseconds. The platform is sold to healthcare systems, hospitals, and HMOs on a SaaS subscription basis and is structured as three integrated modules (Seegnal DRP, Seegnal Insights, Seegnal Guard) plus the MetricsGuard module.

Product overview

Seegnal eHealth is an enterprise healthcare technology company offering the Seegnal Prescription Operating System—a unified platform for precision prescribing and measurable clinical ROI. The platform comprises three integrated modules: Seegnal DRP (Decision Risk Prevention) for point-of-care medication safety and real-time error prevention; Seegnal Insights (Behavior and Outcome Learning) for system-wide prescribing analytics, pattern detection, and cost optimization; and Seegnal Guard (Governance and Optimization) for executive-level policy management and continuous improvement. Together, these three modules form a closed intelligence flywheel where every prescribing event feeds the system, successful interventions inform better future alerts, and Insights findings refine DRP rules. The platform delivers real-time, patient-specific decision support embedded directly in EMR workflows, processing medications, labs, vitals, diagnoses, allergies, and genomic data to reduce medication-related risk while enabling health systems to lower avoidable downstream costs.

Differentiator

Problem solved

Functional benefit

Brands

  • Seegnal DRP: Decision Risk Prevention - Point-of-care safety and rules engine preventing medication errors in real-time.
  • Seegnal Insights
  • Seegnal Guard
  • MetricsGuard

Products and services

  • Seegnal Prescription Operating System Enterprise healthcare technology platform delivering precision prescribing and measurable clinical ROI. The core Prescription OS unifies three integrated layers (Seegnal DRP, Seegnal Insights, Seegnal Guard) into a continuous intelligence flywheel that improves safety, drives adoption, and compounds clinical and financial value over time for healthcare systems, hospitals, and HMOs.
  • Seegnal DRP (Decision Risk Prevention) Real-time prescription safety engine integrated directly into the clinician's workflow, preventing medication errors before they happen through continuous safety logic, drug interaction alerts, renal adjustment recommendations, alternative therapy suggestions, and AI-ranked alternatives from formulary tailored to patient history, allergies, and genetics. Built for clinicians in hospitals, HMOs, and long-term care facilities.
  • Seegnal Insights (Behavior + Outcome Learning) Behavior and outcome learning module providing system-wide analytics that expose prescribing patterns, safety gaps, and cost optimization opportunities. Identifies variation across facilities and providers, detects unsafe patterns and trends, surfaces waste and inefficiencies, and delivers role-specific dashboards for executive, operational, and clinical stakeholders. Built for healthcare system leadership, quality teams, and CFOs.
  • Seegnal Guard (Governance + Optimization) Governance and optimization module providing executive visibility and KPIs for continuous organization-level improvement. Functions as a clinical security center that defines, enforces, and monitors organizational prescribing policies — both clinical and economic — with policy builder, compliance tracking, and automated enforcement at point of care without requiring emails, policing, or training cycles. Built for healthcare executives, CMOs, and clinical leadership.
  • MetricsGuard Clinical decision support module designed to detect patient-specific medication risks, improving clinical safety and reducing adverse drug effects as part of the broader Prescription Intelligence Platform for healthcare systems and providers.

Quantifiable outcome

  • 94% fewer alerts compared to legacy clinical decision support systems
  • +9 more outcomes

Companies that use Seegnal eHealth

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Seegnal eHealth technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature9 records

Seegnal eHealth partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and supporting.

  • AARP AgeTech CollaborativecoreStrategic or Co-development Partner · 5 June 2026Seegnal was accepted into the innovative accelerator program from AARP, the largest U.S. organization serving Americans 50 and older. The program offers mentorship, consumer insights, and potential connections to investors and partners, with focus on U.S. market entry and expansion. This is a strategic accelerator partnership aimed at supporting companies serving Americans aged 50 and older. Participation does not constitute an endorsement by AARP.
  • U.S.-Based Long-Term Care ProvidercoreStrategic or Co-development PartnerSeegnal entered into a non-binding letter of intent dated May 5, 2026, with a U.S.-based long-term care provider to conduct an 8 to 12-week pilot program of its clinical decision support platform for analyzing prescription data and identifying medication-related risks. This pilot marks Seegnal's first engagement in the American healthcare market and represents a deliberate entry point for broader U.S. commercial expansion strategy. The long-term care setting was chosen because the resident population faces elevated risk of adverse drug events that drive avoidable hospitalizations.
  • Tel Aviv Sourasky Medical CentercoreStrategic or Co-development PartnerExpanded deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a leading Israeli public medical center and global referral center. The platform supports approximately 1,200 clinicians and 2,050 medical team members across multiple inpatient and outpatient departments. The medical center treats over 1.5 million patients annually and has adopted Seegnal's patient-centric medication safety standard as a case model for large-scale deployment in public healthcare systems worldwide.
  • CapitaLynx Ltd. (operating as Arx)supportingGTM or Marketing PartnerEngaged CapitaLynx Ltd. (operating as Arx) as an investor relations advisor commencing April 1, 2026, under a three-month initial term at US$49,500 with automatic quarterly renewal. This advisory engagement supports Seegnal's transition from clinical proof-of-concept to structured commercialization.

Scale indicators16 records

Recent moves8 records

Expansion highlights6 records

Seegnal eHealth competitors and assessment

Company assessment

Direct peers

  • MedAware: MedAware is an Israel-based developer of AI-powered medication safety software that flags prescription errors and risks inside EMR workflows. Directly comparable in technology stack (AI on patient data + EMR-native delivery) and in origin (Israel's digital health ecosystem).
  • Arine: Arine is an AI-driven medication intelligence platform for health plans and providers that optimizes prescribing for value-based care. It targets the same precision-prescribing and adverse-drug-event reduction problem Seegnal addresses, with similar data-driven alerting and alternative-ranking capabilities.
  • DrFirst: DrFirst provides ePrescribing, medication management, and clinical decision support technology used by hospitals, EMRs, and pharmacy networks. Comparable on medication-management workflow integration and patient-specific decision support embedded in prescriber systems.
  • First Databank (FDB): First Databank provides drug knowledge databases (FDB MedKnowledge) and clinical decision support modules integrated into EMR workflows for hospital and pharmacy systems. Directly comparable to Seegnal DRP for medication-safety screening at point of care.
  • Tabula Rasa HealthCare (now CareVention): Tabula Rasa HealthCare (now CareVention) provided medication safety analytics and pharmacy risk management focused on reducing adverse drug events for high-risk patients, including long-term care populations. Directly comparable to Seegnal's mission and medication-risk-prevention focus.
  • Wolters Kluwer Clinical Drug Information: Wolters Kluwer's Medi-Span and Lexicomp provide drug-interaction, dosing, and clinical-decision-support content used by hospitals and health systems worldwide. Like Seegnal, it sits inside EMR workflows to prevent prescribing errors and optimize therapy choices.

Broad incumbents

  • Surescripts: Surescripts operates the dominant U.S. ePrescribing network and offers medication history, benefit, and clinical decision support services used by EHRs, pharmacies, and payers. Comparable on the ePrescribing/medication-decision support layer that Seegnal's Prescription OS integrates with.
  • Epic Systems: Epic is the dominant U.S. hospital EMR vendor and offers native clinical decision support (Best Practice Advisories) and embedded medication alerts. Most relevant as the bundled incumbent whose CDS roadmap could expand to subsume Seegnal-type functionality for large U.S. health systems.
  • Oracle Health (Cerner): Oracle Health (formerly Cerner) is a leading hospital EMR vendor with embedded medication alerts and clinical decision support. Notable as both an integration partner of Seegnal (via Oracle Health EMR real-time sync) and a competitor whose first-party CDS could expand.
  • Elsevier Clinical Solutions: Elsevier Clinical Solutions offers drug reference content (Gold Standard) and clinical decision support used by hospitals and EMR vendors. Overlaps with Seegnal DRP content and integration approach but ships as part of Elsevier's broader clinical-information portfolio rather than a standalone prescribing OS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Seegnal eHealth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Seegnal eHealth leadership team

Management profile

Number of profiles

Profiles10 records

Seegnal eHealth funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Seegnal eHealth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seegnal eHealth

What does Seegnal eHealth do?

Seegnal eHealth sells the Seegnal Prescription Operating System, an enterprise clinical decision support platform that delivers real-time, patient-specific medication safety at the point of care. The platform integrates directly into EMR/EHR workflows and processes medications, labs, vitals, organ function, diagnoses, allergies, and genomic data through a hybrid rules-based engine and machine learning models, evaluating 500+ clinical rules in milliseconds. The platform is sold to healthcare systems, hospitals, and HMOs on a SaaS subscription basis and is structured as three integrated modules (Seegnal DRP, Seegnal Insights, Seegnal Guard) plus the MetricsGuard module.

Is Seegnal eHealth a public or private company?

Seegnal eHealth is a public company. It is classified as public and is currently operating.

When was Seegnal eHealth founded?

Seegnal eHealth was founded in 2020. It employs 11 to 50 people.

Where is Seegnal eHealth based?

Seegnal eHealth is headquartered in Rockville, United States, in the North America region.

How does Seegnal eHealth make money?

One revenue line is on record: saaS Clinical Decision Support Subscription.

Who are Seegnal eHealth's main competitors?

Direct peers on record are MedAware, Arine, DrFirst, First Databank (FDB), Tabula Rasa HealthCare (now CareVention) and Wolters Kluwer Clinical Drug Information. Broad incumbents are Surescripts, Epic Systems, Oracle Health (Cerner) and Elsevier Clinical Solutions.

Does Seegnal eHealth have an API?

No public API is recorded for Seegnal eHealth.

What industry is Seegnal eHealth in?

Seegnal eHealth's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms, with a secondary code of HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireSeegnal Inc. Announces Extension of its Non-Brokered Private PlacementSeegnal Inc. extended its non-brokered private placement to up to 6,607,143 units at $0.28 each, for gross proceeds up to CDN$1,850,000. The second and final tranche is expected to close on or about October 31, 2026, subject to regulatory approvals.Financial PostSeegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private PlacementSeegnal Inc. announced the closing of the first tranche of its upsized and extended private placement, with the company reserving the right to close a final tranche pending regulatory approval, including from the TSXV. The press release does not disclose the amount raised, the number of shares sold, or the use of proceeds.GlobeNewswireSeegnal Successfully Initiates First U.S. Pilot ProgramSeegnal Inc. initiated its first U.S. pilot program with a long-term care provider, following a May 19, 2026 letter of intent. The pilot is expected to run 8-12 weeks, with a potential extended evaluation. The company aims to reduce medication-related harm in nursing facilities, where adverse drug events cause an estimated 99,628 emergency hospitalizations annually.GlobeNewswireSeegnal Inc. Announces Non-Brokered Private PlacementSeegnal Inc. announced a non-brokered private placement of up to 4,642,857 units at $0.28 each, raising up to CDN$1,300,000. Proceeds will fund general corporate and working capital, with the offering expected to close by June 30, 2026. Insiders are expected to subscribe, and the deal is subject to TSXV approval.The Canadian Press NewsSEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026Seegnal Inc. announced that its management cease trade order will expire on May 16, 2026, and filed its audited 2025 financials on May 13, 2026. The order applied only to the CEO and CFO, leaving public trading unaffected. The company confirmed it is current with continuous disclosure obligations.The Canadian Press NewsYanik Guillemette: Canada’s Employment Crisis and Cost-of-Living Collapse Signal Urgent Need for Economic RealignmentYanik Guillemette warns Canada is entering a dangerous economic spiral, citing over 112,000 jobs lost since January 2026 and Quebec's 91,000 net losses. Youth unemployment hit 14.3% and unemployment rose to 6.9% nationally. He calls for structural change, citing rising theft and weakening social contract.The Canadian Press NewsCGTN: Head-of-state diplomacy anchors growing China-Russia partnershipRussian President Vladimir Putin will visit China from May 19 to 20, marking the 25th anniversary of the China-Russia treaty and the 30th of their strategic partnership. Bilateral trade reached $227.9 billion in 2025, and the two sides have met over 40 times since 2013.GlobeNewswireSeegnal Inc. Announces Update to Delay in Filing 2025 Annual Financial Statements and Related Management Discussion and AnalysisSeegnal Inc. announced it cannot file its 2025 annual financial statements by the deadline, citing the external auditor's timing. The company expects to file by May 13, 2026, and has applied for a management cease trade order. It will continue to comply with alternative information guidelines.GlobeNewswireSeegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization ReadinessSeegnal eHealth Ltd., the Israeli subsidiary of Seegnal Inc., received the Gold Mark from the Standards Institution of Israel. The certification recognizes its three ISO certifications: ISO 13485, ISO 27799, and ISO 27001. The award reinforces the company's commercialization readiness and enterprise-grade platform status.INNSeegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm SummitSeegnal presented real-world evidence on reducing fall risk in geriatric patients at the Caltcm Summit. The company showcased data related to its efforts in this medical field.